Mother Discovers BREAKTHROUGH For NON-VERBAL Autistics - And She's Not the Only One So Very Happy

Oct 02, 2025

A mother on TikTok has a NONVERBAL autistic son, and she’s been watching HHS and RFK Jr. like a HAWK, especially after they announced the supercharged research into autism.

After the recent announcements about Tylenol, she looked into Leucovorin because NOTHING else helped her son.

“He’s been on on this medication for LESS THAN 48 hours and my son just SPOKE FOR THE FIRST TIME!“

“My nonverbal son just spoke for the FIRST TIME in over THREE YEARS!“

This. Is. HUGE ‼️

BE SURE TO SHARE THIS STORY!

Imagine how many more children would have LIFE CHANGING results if the TRUTH was told more!

Kudos to this mother for being BRAVE ENOUGH to speak the TRUTH!

» IMPORTANT: This is not widely known and counsel with a naturopathic doctor (ND) or a doctor of naturopathic medicine (NMD) before starting treatments - they may need to learn what you are discovering as well.

She is Not the Only One to Discover the Positive Effects of Leucovorin on Nonverbal Autism

If you are sensing there is a pattern of inexpensive drugs first created decades ago that are providing cures the expensive Big Pharma drugs can’t - you are not alone either.

Leucovorin is at least the 5th such drug unearthed since the beginning of COVID in 2020…

Yeah, THAT…

About Leucovorin

Leucovorin, also known as folinic acid, is a derivative of folic acid (vitamin B9).

It is primarily used to counteract the toxic effects of methotrexate and other folate antagonists in cancer chemotherapy, and to treat certain types of anemia.

Recently, the FDA has initiated the approval of leucovorin calcium tablets for patients with Cerebral Folate Deficiency (CFD), a neurological condition that affects folate transport into the brain.

Individuals with CFD can have developmental delays with autistic features, seizures, and problems with movement and coordination.

While leucovorin is not a cure for autism, studies suggest it may improve verbal communication and other autism-related symptoms in some children, particularly those with cerebral folate deficiency.

The FDA’s move to expand its label has been prompted by the Trump administration.

Perspectives

Support for Leucovorin in Autism Treatment

Leucovorin has shown promise in improving language pathways and verbal communication in non-verbal autistic children with cerebral folate deficiency.

The FDA has initiated the approval of leucovorin for children and adults with Cerebral Folate Deficiency (CFD), a condition linked to autistic features.

Parents have reported ‘huge progress’ and non-verbal children speaking for the first time after starting leucovorin.

Leucovorin is an inexpensive, generic drug, making it an accessible option for some families.

Caution and Need for More Research on Leucovorin for Autism

While leucovorin shows promise, scientific findings on its safety and efficacy for autism are still in early stages, and more research is needed.

The FDA’s approval process for leucovorin for autism has drawn expert criticism for bypassing standard review.

Clinical trials on leucovorin for autism have been limited, involving few participants, and results have not always been replicated or looked at the same outcomes.

Some autism researchers and advocates argue the announcement of its approval for autism is premature and that while the drug is safe for cancer patients, its safety for children with autism has not been adequately studied.

Discussion about this post

Ready for more?